MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹72 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 25.94 | |
| Mar2024 | ₹123 Cr | 25.78 | |
| Mar2023 | ₹98 Cr | 22.36 | |
| Mar2022 | ₹80 Cr | 10.74 | |
| Mar2021 | ₹72 Cr | - | |
Compare Long Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹85,049.2 Cr | -1.1% | -8.2% | -17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.1% |
-8.2% |
-17.5% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses